Teva Pharmaceutical Industries Limited
TEVA
Helyezés a részvények között
#13226
Teva Pharmaceutical Industries Limited operates as a prominent global... Teva Pharmaceutical Industries Limited operates as a prominent global pharmaceutical firm, involved in the research, development, manufacturing, marketing, and distribution of generic, specialized, and biopharmaceutical products throughout North America, Europe, and other international regions. The company's diverse portfolio encompasses sterile preparations, hormonal therapies, high-potency drugs, and cytotoxic substances, supplied in a wide array of dosage forms such as tablets, capsules, injectable solutions, inhalants, oral liquids, transdermal patches, topical ointments, and creams. Furthermore, Teva develops, produces, and sells active pharmaceutical ingredients (APIs). A significant portion of its research and product development is concentrated on the central nervous system, pain management, respiratory illnesses, and oncology. Leading products for the central nervous system include Copaxone, utilized for relapsing multiple sclerosis; AJOVY, an option for migraine prevention; and AUSTEDO, prescribed for tardive dyskinesia and chorea linked to Huntington's disease. Within the respiratory domain, addressing asthma and chronic obstructive pulmonary disease, Teva offers products like ProAir, QVAR, various Digihaler and RespiClick formulations, along with BRALTUS and CINQAIR/CINQAERO. Their oncology division features treatments such as Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. The company also collaborates with MedinCell on the creation and commercialization of multiple extended-release injectable products, including a risperidone suspension designed for individuals with schizophrenia. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.
Részvényárfolyam
$41.51
Utolsó szinkronizálás: 2026-10-16
Piaci kapitalizáció
$483.77M
Változás (1 nap)
-0.85%
Változás (1 év)
107.47%
Ország
IL
Kereskedés Teva Pharmaceutical Industries Limited (TEVA)
Kategória
Healthcare
Piaci kapitalizációja Teva Pharmaceutical Industries Limited(TEVA)
Piaci kapitalizáció: $483.77M
October 2026-ban a Teva Pharmaceutical Industries Limited piaci kapitalizációja $483.77M. Ez alapján a Teva Pharmaceutical Industries Limited a világ 13226th legértékesebb vállalata a piaci kapitalizáció szerint. A piaci kapitalizáció egy tőzsdén jegyzett vállalat összes részvényének piaci értéke, amelyet gyakran használnak a vállalat értékének mérésére.
Teva Pharmaceutical Industries Limited piaci kapitalizációjának története 2010 és 2026 között
TEVA összehasonlítva az 5 legnépszerűbb stocks
